TEG® functional fibrinogen analysis may overestimate fibrinogen levels

Anesthesia and Analgesia

Volumn 118, Issue 5, 2014, Pages 933-935

  Ågren, Anna ^a,b   Wikman, Agneta Taune ^a,c   Östlund, Anders ^a   Edgren, Gustaf ^a,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Sweden Karolinska Institutet Department of Clinical Sciences Danderyd Hospital Stressrehab FoU Danderyd   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

ADULT; ARTICLE; BLOOD DONOR; CANCER SURGERY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STAB WOUND; SURGICAL PATIENT; THROMBOELASTOGRAPHY; TRAFFIC ACCIDENT; AGED; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; REPRODUCIBILITY;

ADULT; AGED; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; THROMBELASTOGRAPHY;

EID: 84902166062     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000172     Document Type: Article

References (14)

1. Spahn DR. Severe bleeding in surgical and trauma patients: The role of fibrinogen replacement therapy. Thromb Res 2012;130:S15-9.
2. Karlsson M, Ternström L, Hyllner M, Baghaei F, Nilsson S, Jeppsson A. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: A prospective observational study. Transfusion 2008;48:2152-8.
3. Carling MS, Jeppsson A, Wessberg P, Henriksson A, Baghaei F, Brisby H. Preoperative fibrinogen plasma concentration is associated with perioperative bleeding and transfusion requirements in scoliosis surgery. Spine (Phila Pa 1976) 2011;36:549-55.
4. Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost 2009;102: 137-44.
5. Fenger-Eriksen C, Jensen TM, Kristensen BS, Jensen KM, Tønnesen E, Ingerslev J, Sørensen B. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: A randomized, placebo-controlled clinical trial. J Thromb Haemost 2009;7:795-802.
6. Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M. Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo- controlled trial. J Thorac Cardiovasc Surg 2013;145:S178-85.
7. Ågren A, Wikman AT, Holmström M, Östlund A, Edgren G. Thromboelastography (TEG®) compared to conventional coagulation tests in surgical patients-a laboratory evaluation. Scand J Clin Lab Invest 2013;73:214-20.
8. Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: An in vitro model. Br J Anaesth 2009;102:793-9.
9. Ogawa S, Szlam F, Bolliger D, Nishimura T, Chen EP, Tanaka KA. The impact of hematocrit on fibrin clot formation assessed by rotational thromboelastometry. Anesth Analg 2012;115:16-21.
10. Spiezia L, Radu C, Marchioro P, Bertini D, Rossetto V, Castelli M, Pagnan A, Sørensen B, Simioni P. Peculiar whole blood rotation thromboelastometry (Rotem) profile in 40 sideropenic anaemia patients. Thromb Haemost 2008;100: 1106-10.
11. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
12. Solomon C, Sørensen B, Hochleitner G, Kashuk J, Ranucci M, Schöchl H. Comparison of whole blood fibrin-based clot tests in thrombelastography and thromboelastometry. Anesth Analg 2012;114:721-30.
13. Nielsen VG, Kirklin JK, Hoogendoorn H, Ellis TC, Holman WL. Thrombelastographic method to quantify the contribution of factor XIII to coagulation kinetics. Blood Coagul Fibrinolysis 2007;18:145-50.
14. Lang T, Toller W, Gütl M, Mahla E, Metzler H, Rehak P, März W, Halwachs-Baumann G. Different effects of abciximab and cytochalasin D on clot strength in thrombelastography. J Thromb Haemost 2004;2:147-53.